News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Brandon Sheffield: Canadian Expert Consensus on Predictive Biomarker Testing in Gastric and GEJ Adenocarcinoma
cancerhealth.com
Dec 13, 2024, 16:02

Brandon Sheffield: Canadian Expert Consensus on Predictive Biomarker Testing in Gastric and GEJ Adenocarcinoma

Brandon Sheffield, Diagnostic and Molecular Pathologist at William Osler Health System, shared on LinkedIn:

“Great new resource for pathologists and oncologists!

A lot has changed in gastric cancer, we have a lot of new therapies to offer. Pathologists are playing a big part here with Claudin18 becoming the latest IHC biomarker coming into play for precision medicine in gastric cancer patients.

Read on to see some helpful recommendations from Canadian pathologists and oncologists.”

Canadian Consensus Recommendations for Predictive Biomarker Testing in Gastric and Gastroesophageal Junction Adenocarcinoma

Authors: Christine Brezden-Masley, Pierre O. Fiset, Carol C. CheungThomas Arnason, Justin Bateman, Martin Borduas, Gertruda Evaristo, Diana N. Ionescu, Howard J. Lim, Brandon S. Sheffield, Sara V. Soldera, Catherine J. Streutker

Brandon Sheffield: Canadian Expert Consensus on Predictive Biomarker Testing in Gastric and GEJ Adenocarcinoma

Brandon S. Sheffield Brandon Sheffield cancer Carol C. CheungThomas Arnason Catherine J. Streutker Christine Brezden-Masley Diana N. Ionescu Gertruda Evaristo Howard J. Lim Justin Bateman Martin Borduas OncoDaily Oncology Pierre O. Fiset Sara V. Soldera
Special Coverage
Blog
Dec 13, 2024, 16:02
Brandon Sheffield: Canadian Expert Consensus on Predictive Biomarker Testing in Gastric and GEJ Adenocarcinoma
Blog
Dec 13, 2024, 16:01
Pancreatic cancer is one of the leading causes of cancer-related death in NSW - Cancer Institute NSW
Insight
Dec 13, 2024, 15:59
Arndt Vogel: Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC
Blog
Dec 13, 2024, 15:52
SOLTI-2103 VALENTINE Trial: Phase II Trial of Neoadjuvant Patritumab Deruxtecan vs. Chemotherapy for High-Risk HR+/HER2- Early Breast Cancer
Insight
Dec 13, 2024, 15:51
Insights from SABCS 2024 part 2
Societies
Dec 13, 2024, 15:39
Best of 66th ASH Annual Meeting and Exposition
Blog
Dec 13, 2024, 15:35
Barend Sikkema: Body weight gain associated with alectinib in patients with ALK positive NSCLC
Blog
Dec 13, 2024, 15:19
Megan-Claire Chase: Finally meeting top six Cancerlebrities
Blog
Dec 13, 2024, 15:19
Neoadjuvant treatment with an anthracycline-free regimen in Breast Cancer - Breast International Group
Insight
Dec 13, 2024, 14:30
Day 2 Highlights of SABCS24 by Erika Hamilton
Insight
Dec 13, 2024, 14:26
Khaled Elsayad: Pattern of care analysis of primary cutaneous lymphomas radiotherapy
Blog
Dec 13, 2024, 14:22
Eugen Leo: Advancing Cancer Care - Tackling Cachexia and Tumor Resistance